ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.2605
Delayed Data
As of Jun 18
 -0.0095 / -3.52%
Today’s Change
0.17
Today|||52-Week Range
2.79
-17.56%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.27
Today’s open0.26
Day’s range0.26 - 0.27
Volume239,369
Average volume (3 months)959,728
Market cap$12.2M
Data as of 3:59pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+84.41%
Earnings growth (this year)+47.97%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio0.6
Price/Sales--
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc0.000.00%
YTENYield10 Bioscience I...+0.05+3.77%
BASIBioanalytical System...+0.07+4.35%
OPGNOpGen Inc-0.11-4.91%
Data as of 4:00pm ET, 06/18/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Westlake Village, California

Forecasts